We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+27.83%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.06B
AUM Growth
+$763M
Cap. Flow
-$5.38M
Cap. Flow %
-0.13%
Top 10 Hldgs %
19.92%
Holding
716
New
62
Increased
184
Reduced
392
Closed
41

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.96M
2
LRCX icon
Lam Research
LRCX
+$7.05M
3
MSGS icon
Madison Square Garden
MSGS
+$5.17M
4
NVDA icon
NVIDIA
NVDA
+$5.15M
5
MGNX icon
MacroGenics
MGNX
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Healthcare 15.46%
3 Industrials 10.94%
4 Communication Services 9.16%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
76
United Parks & Resorts
PRKS
$2.19B
$14.7M 0.36%
991,767
+93,302
+10% +$1.37M
GILD icon
77
Gilead Sciences
GILD
$165B
$14.7M 0.36%
190,590
-11,582
-6% -$888K
MGNX icon
78
MacroGenics
MGNX
$233M
$14.6M 0.36%
523,306
-239,064
-31% -$4.15M
AVGO icon
79
Broadcom
AVGO
$1.76T
$14.5M 0.36%
459,410
-21,050
-4% -$589K
BABA icon
80
Alibaba
BABA
$276B
$14.3M 0.35%
66,306
-5,400
-8% -$1.12M
RTX icon
81
RTX Corp
RTX
$290B
$13.8M 0.34%
223,781
+49,603
+28% +$3.1M
VCSH icon
82
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$13.8M 0.34%
166,590
+26,103
+19% +$2.12M
PEP icon
83
PepsiCo
PEP
$196B
$13.8M 0.34%
104,091
+5,634
+6% +$743K
ESPR
84
DELISTED
Esperion Therapeutics
ESPR
$13.7M 0.34%
267,683
-1,830
-0.7% -$76.6K
RARE icon
85
Ultragenyx Pharmaceutical
RARE
$2.46B
$13.6M 0.34%
174,199
-4,572
-3% -$303K
STZ icon
86
Constellation Brands
STZ
$22.5B
$13.4M 0.33%
76,786
-4,918
-6% -$819K
NEE icon
87
NextEra Energy
NEE
$184B
$13.4M 0.33%
222,968
+620
+0.3% +$37.1K
VV icon
88
Vanguard Large-Cap ETF
VV
$51.2B
$13.3M 0.33%
93,141
-3,803
-4% -$514K
CVS icon
89
CVS Health
CVS
$135B
$13M 0.32%
200,016
-15,750
-7% -$992K
BAC icon
90
Bank of America
BAC
$429B
$12.9M 0.32%
545,143
-4,163
-0.8% -$98.4K
LMT icon
91
Lockheed Martin
LMT
$131B
$12.9M 0.32%
35,440
+552
+2% +$208K
SRPT icon
92
Sarepta Therapeutics
SRPT
$1.64B
$12.8M 0.32%
79,666
-1,570
-2% -$214K
BLK icon
93
Blackrock
BLK
$167B
$12.8M 0.31%
23,466
+2,997
+15% +$1.51M
LAZ icon
94
Lazard
LAZ
$4B
$12.7M 0.31%
444,352
+2,619
+0.6% +$71K
ACN icon
95
Accenture
ACN
$106B
$12.5M 0.31%
58,231
-1,333
-2% -$252K
ADSK icon
96
Autodesk
ADSK
$51.8B
$12.3M 0.3%
51,602
-2,470
-5% -$486K
AXP icon
97
American Express
AXP
$224B
$11.9M 0.29%
125,426
+11,927
+11% +$1.1M
BA icon
98
Boeing
BA
$169B
$11.8M 0.29%
64,566
-5,724
-8% -$880K
VSH icon
99
Vishay Intertechnology
VSH
$4.6B
$11.7M 0.29%
765,002
-13,728
-2% -$214K
BAX icon
100
Baxter International
BAX
$12.8B
$11.3M 0.28%
130,885
-981
-0.7% -$85.5K

Similar funds

Pinnacle Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Pinnacle Associates held 716 positions worth $4.06B, up 23% from $3.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q2 2020 filing shows 62 new, 184 increased, 392 reduced and 41 closed positions. Its largest new stake was Rogers Corp: 56,390 shares worth $7.03M. The largest sale was Apple, an estimated $7.96M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Pinnacle Associates's largest Q2 2020 buy was Rogers Corp: 56,390 shares worth $7.03M.
  • Pinnacle Associates added most to Johnson & Johnson in Q2 2020, an estimated $15.9M increase.
  • Pinnacle Associates's biggest Q2 2020 reduction was Apple, cutting an estimated $7.96M.
  • Pinnacle Associates fully exited Portola Pharmaceuticals, Inc. in Q2 2020, selling an estimated $3.38M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $4.06B portfolio in Q2 2020.
  • Pinnacle Associates opened 62 new positions and closed 41 in Q2 2020.
  • Pinnacle Associates's portfolio value rose 23% quarter-over-quarter to $4.06B.

Based on Pinnacle Associates's 13F filing for Q2 2020, filed 14 Aug 2020.